Other languages FUSN PHAR

Equities

FUSN

CA36118A1003

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-19 pm EDT			5-day change	1st Jan Change
21.26 ^USD	+0.05%		-0.23%	+121.23%

Apr. 16	TD Cowen Downgrades Fusion Pharmaceuticals to Hold	MT
Apr. 09	Fusion Pharmaceuticals Inc. Presents Interim Efficacy and Safety Data from the Phase 2 TATCIST Open-Label Clinical Trial Evaluating FPI-2265	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Fusion Pharmaceuticals Inc. Presents Interim Efficacy and Safety Data from the Phase 2 TATCIST Open-Label Clinical Trial Evaluating FPI-2265	Apr. 09
Fusion Pharmaceuticals Narrows Q4 Loss; Enters Sale Deal With AstraZeneca	Mar. 20
Fusion Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 20
Fusion Pharmaceuticals Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 20
Sector Update: Health Care Stocks Rise Late Afternoon	Mar. 19
Sector Update: Health Care Stocks Higher in Tuesday Afternoon Trading	Mar. 19
Sector Update: Health Care	Mar. 19
Top Midday Gainers	Mar. 19
Top Stories at Midday: February US Housing Starts Rise; AstraZeneca to Acquire Fusion Pharmaceuticals; IFF to Sell Pharma Solutions Unit; Unilever to Spin Off Ice Cream Unit; MicroStrategy Completes Notes Offering; Super Micro Computer Files Shelf; Nvidia Unveils Latest GPU	Mar. 19
Sector Update: Health Care Stocks Lean Lower Premarket Tuesday	Mar. 19
Wall Street Set to Open Lower Ahead of Two-Day Fed Meeting; Housing Starts Surge Higher Than Expected	Mar. 19
Sector Update: Health Care	Mar. 19
Fed Policy Meeting in Focus as Exchange-Traded Funds, Equity Futures Fall Pre-Bell Tuesday	Mar. 19
US Futures Trend Lower in Tuesday's Premarket as Investors Await Start of 2-Day Fed Meeting	Mar. 19
Top Premarket Gainers	Mar. 19
AstraZeneca Strikes $2.4 Billion Deal to Buy Fusion Pharmaceuticals	Mar. 19
Fusion Pharmaceuticals Signs Licensing Deal, Settles Patent Dispute	Feb. 16
Top Premarket Gainers	Jan. 05
Fusion Pharmaceuticals Outlines Fund Guidance, Operational Updates; Shares Surge Premarket	Jan. 05
Fusion Pharmaceuticals Outlines Fund Guidance, Operational Updates; Shares Rise After Hours	Jan. 04

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages FUSN PHAR

Equities

FUSN

CA36118A1003

Other languages

Filters